Table 2.
PAM50 gene expression levels by BMI around breast cancer diagnosis and menopausal status, LACE and Pathways cohorts
| Underweight | Normal weight | Overweight | Mildly Obese | Highly Obese | p valuea | |
|---|---|---|---|---|---|---|
| <18.5 kg/m2 | 18.5-24.9 kg/m2 | 25.0-29.9 kg/m2 | 30-34.9 kg/m2 | ≥35.0 kg/m2 | ||
| mean | mean | mean | mean | mean | ||
| n=13 | n=658 | n=509 | n=290 | n=206 | ||
| Overall (n=1,676) | ||||||
| ESR1 | 10.95 | 12.31 | 12.32 | 12.43 | 11.54 | 0.03 |
| PGR | 6.73 | 7.98 | 7.82 | 8.33 | 7.76 | 0.86 |
| ERBB2 | 13.18 | 13.84 | 13.78 | 13.71 | 13.68 | 0.08 |
| Proliferation | 9.07 | 8.64 | 8.75 | 8.79 | 9.12 | 0.02 |
| Premenopausal (n=428) | ||||||
| ESR1 | 10.61 | 11.93 | 11.78 | 11.70 | 10.78 | 0.01 |
| PGR | 7.57 | 7.74 | 7.51 | 8.44 | 7.64 | 0.79 |
| ERBB2 | 12.84 | 13.76 | 13.96 | 13.87 | 13.42 | 0.32 |
| Proliferation | 9.62 | 9.16 | 9.17 | 9.13 | 9.15 | 0.85 |
| Postmenopausal (n=1,135) | ||||||
| ESR1 | 11.37 | 12.50 | 12.54 | 12.73 | 11.80 | 0.17 |
| PGR | 5.71 | 8.01 | 7.96 | 8.31 | 7.77 | 0.76 |
| ERBB2 | 13.59 | 13.87 | 13.73 | 13.67 | 13.76 | 0.15 |
| Proliferation | 8.40 | 8.49 | 8.60 | 8.66 | 9.09 | 0.01 |
NOTE: Raw values are re-scaled by adding a constant of 10 units to interpret and preserve rank order.
a P values from generalized linear model (GLM) for gene expression.